Pfizer, U.K. experts seek approval for stem cell clinical trial

10/9/2011 | Wall Street Journal, The

Pfizer and scientists at the University College London's Institute of Ophthalmology have asked U.K. regulators to allow them to start a clinical trial of retinal cells, derived from human embryonic stem cells, in patients with age-related macular degeneration. They hope to conduct the U.K. study in 2012.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL